Switch in FOXA1 status associates with endometrial cancer progression
about
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.The Estrogen Receptor α-Cistrome Beyond Breast Cancer.The mutational spectrum of FOXA2 in endometrioid endometrial cancer points to a tumor suppressor role.FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy.FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome
P2860
Switch in FOXA1 status associates with endometrial cancer progression
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Switch in FOXA1 status associates with endometrial cancer progression
@ast
Switch in FOXA1 status associates with endometrial cancer progression
@en
type
label
Switch in FOXA1 status associates with endometrial cancer progression
@ast
Switch in FOXA1 status associates with endometrial cancer progression
@en
prefLabel
Switch in FOXA1 status associates with endometrial cancer progression
@ast
Switch in FOXA1 status associates with endometrial cancer progression
@en
P2093
P2860
P50
P1433
P1476
Switch in FOXA1 status associates with endometrial cancer progression
@en
P2093
Anne M Oyan
Helga B Salvesen
Henrica M J Werner
Ingvild Løberg Tangen
Kanthida Kusonmano
Karl Henning Kalland
Kjell Petersen
P2860
P304
P356
10.1371/JOURNAL.PONE.0098069
P407
P577
2014-05-21T00:00:00Z